Hacker News with Generative AI: HIV

Viral trapdoor: Scientists discover how a protein protects against HIV, herpes (medicalxpress.com)
A group of researchers discovered how a protein linked to the human immune system wards off HIV-1 and herpes simplex virus-1 by assembling structures in the cell that lure in these viruses and then trap them or even take them apart.
Gilead agrees to license twice-yearly HIV drug for poor countries (statnews.com)
In response to increased criticism of its pricing, Gilead Sciences has reached voluntary licensing deals with companies to make generic versions of its twice-yearly HIV medicine, lenacapavir, in 120 mostly low- and lower-middle-income countries.
Gilead's twiceyearly shot cut HIV infections by 96% in trial (cnbc.com)
HIV drug could be made for just $40 a year for every patient (theguardian.com)
Engineered Virus Steals Proteins from HIV, Pointing to New Therapy (nytimes.com)
Prevention of HIV (science.org)
New drug shows promise in clearing HIV from brain (sciencedaily.com)
Twice-yearly injection offers 100% protection against HIV (nbcnews.com)
With seventh person seemingly cured of HIV, signs of hope for a broader cure (fiercebiotech.com)
60-year-old German man likely seventh person to be effectively cured from HIV (rfi.fr)
New HIV Prevention Drug Shows 100% Efficacy in Clinical Trial (sciencealert.com)
Over 2,400 patients may have been exposed to HIV, hepatitis at Oregon hospitals (cbsnews.com)
HIV breakthrough: Trial shows drug provides 100% protection (universityworldnews.com)
A new way to prevent HIV delivers dramatic results in trial (npr.org)
Gilead shot prevents all HIV cases in trial (bloomberg.com)
HIV Life Cycle – animated and narrated [video] (vimeo.com)
A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans (dukehealth.org)